Point-of-care diagnosis of cervical cancer: potential protein biomarkersin cervicovaginal fluid

Cervical cancer (CxCa) is preventable and treatable via vaccination screening. Cervicovaginal fluid (CVF) represents the physiological components of female genital tract. These are suitable to be utilized for clinical purposes, therefore, making CVF a material disease screening approaches. Due high false-negative result rates low attendance current expensive routine CxCa methods, it has become more important develop point-of-care (POC) method that every single woman could reach worldwide. For this purpose, various self-usage apparatus have been developed human papilloma virus (HPV) infection. Furthermore, due specificity HPV tests clearance rate infections, many patients undergo overtreatment. Since proteins play an role in cellular process carcinogenesis, appropriate use simple test detection carcinogenesis. In article, POC studies discovery protein biomarkers will overviewed consider development can used rapid conceivable CxCa.